| Title |
New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, June 2014
|
| DOI | 10.2147/tcrm.s49063 |
| Pubmed ID | |
| Authors |
Grigoris T Gerotziafas, Isabelle Mahé, Ismail Elalamy |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Hungary | 1 | 1% |
| Denmark | 1 | 1% |
| Slovenia | 1 | 1% |
| Unknown | 77 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 19% |
| Student > Master | 11 | 14% |
| Other | 10 | 12% |
| Student > Doctoral Student | 7 | 9% |
| Student > Postgraduate | 7 | 9% |
| Other | 17 | 21% |
| Unknown | 14 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 44% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 11% |
| Agricultural and Biological Sciences | 5 | 6% |
| Economics, Econometrics and Finance | 3 | 4% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Other | 10 | 12% |
| Unknown | 16 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2015.
All research outputs
#15,168,964
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#667
of 1,323 outputs
Outputs of similar age
#121,974
of 240,959 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#12
of 28 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,959 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.